These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Kychenthal A; Dorta P Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474 [TBL] [Abstract][Full Text] [Related]
5. Coats' disease: treatment with intravitreal bevacizumab and laser photocoagulation. Stergiou PK; Symeonidis C; Dimitrakos SA Acta Ophthalmol; 2009 Sep; 87(6):687-8. PubMed ID: 18976310 [No Abstract] [Full Text] [Related]
6. Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity. Suk KK; Berrocal AM; Murray TG; Rich R; Major JC; Hess D; Johnson RA J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-4. PubMed ID: 21175113 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Bom Aggio F; Eid Farah M; Melo GB Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511 [No Abstract] [Full Text] [Related]
8. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration. Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity. dell'Omo R; Kulkarni A; Franks WA Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905 [No Abstract] [Full Text] [Related]
10. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction. Ramasubramanian A; Shields CL Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215 [TBL] [Abstract][Full Text] [Related]
11. [Retinopathy of prematurity - pathophysiologic mechanisms and new treatment options]. Stahl A; Aisenbrey S; Krohne TU Klin Monbl Augenheilkd; 2012 Oct; 229(10):1024-9. PubMed ID: 22961043 [TBL] [Abstract][Full Text] [Related]
12. [Prevention and therapy of retinal detachment]. Brihaye-van Geertruyden ; Watillon M Arch Ophtalmol Rev Gen Ophtalmol; 1972 Oct; 32(10):687-704. PubMed ID: 4267680 [No Abstract] [Full Text] [Related]
13. [Degenerative maculopathy (in younger patients)]. Haas G; Treiblmayr B; Kralinger M; Bechrakis NE Klin Monbl Augenheilkd; 2014 Dec; 231(12):1239-55. PubMed ID: 25393434 [No Abstract] [Full Text] [Related]
14. Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration. Chen E; Kaiser RS; Vander JF Retina; 2007; 27(4):445-50. PubMed ID: 17420696 [TBL] [Abstract][Full Text] [Related]
15. [VEGF antibodies as therapy for retinopathy of prematurity]. Oberacher-Velten IM; Helbig H Klin Monbl Augenheilkd; 2010 Sep; 227(9):694-700. PubMed ID: 20845249 [TBL] [Abstract][Full Text] [Related]
16. Anti-vascular endothelial growth factor agents for pediatric retinal diseases. Wykoff CC; Houston SK; Berrocal AM Int Ophthalmol Clin; 2011; 51(1):185-99. PubMed ID: 21139484 [No Abstract] [Full Text] [Related]
17. Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin. Tranos P; Gemenetzi M; Papandroudis A; Chrisafis C; Papadakos D Eye (Lond); 2008 Jun; 22(6):862. PubMed ID: 18007674 [No Abstract] [Full Text] [Related]
18. [New therapeutic approaches in the treatment of retinopathy of prematurity]. Jandeck C Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of retinal detachment of the course of retinopathy of prematurity]. Prost ME Klin Oczna; 2003; 105(5):322-5. PubMed ID: 14746190 [TBL] [Abstract][Full Text] [Related]
20. A potential therapeutic strategy for capillary hemangioma with new anti-vascular endothelial growth factor (anti-VEGF) agents. Mehriar M; Attarzadeh A; Naseri M; Owji N; Siyoofi S; Mosallaei M Med Hypotheses; 2007; 69(4):951. PubMed ID: 17408872 [No Abstract] [Full Text] [Related] [Next] [New Search]